Literature DB >> 11776507

The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.

J Manonai1, U Theppisai, S Suthutvoravut, U Udomsubpayakul, A Chittacharoen.   

Abstract

OBJECTIVES: To compare the effects of estradiol vaginal tablet with conjugated estrogen cream on urogenital symptoms, vaginal health index, vaginal cytology, endometrial thickness, and plasma estradiol level in postmenopausal women.
METHODS: Fifty-three women with urogenital symptoms were randomized to local vaginal treatment of 25 microg estradiol tablet or 1 g of conjugated estrogen cream for 12 weeks. They were assessed for urogenital symptoms, vaginal health index, vaginal cytology, endometrial thickness and estradiol level.
RESULTS: Forty-eight women completed the treatment. Both groups showed improvement of urogenital symptoms, vaginal health index, and vaginal cytology after the first 4 weeks of treatment. Conjugated estrogen cream showed superior efficacy in alleviating vaginal dryness and dyspareunia. Two cases of endometrial proliferation were noted.
CONCLUSIONS: Estradiol vaginal tablet and conjugated estrogen cream were effective in treating urogenital symptoms, the restoration of normal vaginal epithelium and reduction of vaginal pH in postmenopausal women. However, 2 cases of endometrial proliferation were noted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11776507     DOI: 10.1111/j.1447-0756.2001.tb01266.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  10 in total

Review 1.  Assessment of vaginal atrophy: a review.

Authors:  M A Weber; J Limpens; J P W R Roovers
Journal:  Int Urogynecol J       Date:  2014-07-22       Impact factor: 2.894

Review 2.  Sexual dysfunction in the older woman: an overview of the current understanding and management.

Authors:  Kathleen E Walsh; Jennifer R Berman
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

3.  Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.

Authors:  David D Rahn; Meadow M Good; Shayzreen M Roshanravan; Haolin Shi; Joseph I Schaffer; Ravinder J Singh; R Ann Word
Journal:  J Clin Endocrinol Metab       Date:  2014-06-20       Impact factor: 5.958

Review 4.  Management of Vaginal Atrophy: Implications from the REVIVE Survey.

Authors:  Susan Wysocki; Sheryl Kingsberg; Michael Krychman
Journal:  Clin Med Insights Reprod Health       Date:  2014-06-08

5.  Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review.

Authors:  Ginger D Constantine; Shelli Graham; Kate Lapane; Kathleen Ohleth; Brian Bernick; James Liu; Sebastian Mirkin
Journal:  Menopause       Date:  2019-07       Impact factor: 2.953

Review 6.  Local oestrogen for vaginal atrophy in postmenopausal women.

Authors:  Anne Lethaby; Reuben Olugbenga Ayeleke; Helen Roberts
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31

7.  Design of a Randomized Clinical Trial of Perioperative Vaginal Estrogen Versus Placebo With Transvaginal Native Tissue Apical Prolapse Repair (Investigation to Minimize Prolapse Recurrence of the Vagina using Estrogen: IMPROVE).

Authors:  David D Rahn; Holly E Richter; Vivian W Sung; Wilma I Larsen; Linda S Hynan
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-01-01       Impact factor: 1.913

Review 8.  Local Oestrogen for Pelvic Floor Disorders: A Systematic Review.

Authors:  M A Weber; M H Kleijn; M Langendam; J Limpens; M J Heineman; J P Roovers
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  A comparative study of vaginal estrogen cream and sustained-release estradiol vaginal tablet (Vagifem) in the treatment of atrophic vaginitis in Isfahan, Iran in 2010-2012.

Authors:  Pardis Hosseinzadeh; Atallah Ghahiri; Freshteh Daneshmand; Mojdeh Ghasemi
Journal:  J Res Med Sci       Date:  2015-12       Impact factor: 1.852

10.  Systemic estradiol levels with low-dose vaginal estrogens.

Authors:  Richard J Santen; Sebastian Mirkin; Brian Bernick; Ginger D Constantine
Journal:  Menopause       Date:  2020-03       Impact factor: 3.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.